Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The epidemic of obesity is recognized as one of the most important public health problems facing the world today. According to 2014 World Health Organization (WHO) data,1 39% of adults worldwide are overweight (body mass index, BMI ≥ 25 kg/m2) and 13% of adults are obese (BMI ≥ 30 kg/m2). Thus, more than half a billion adults worldwide are classified as obese. The prevalence of obesity varies by geographical region, gender and income level. The highest prevalence is found in the USA (61% overweight, 27% obese), closely followed by Europe (59% overweight, 23% obese), with the lowest prevalence in South–East Asia (22% overweight, and 5% obese). In Europe, the vast majority of countries have an overweight prevalence of more than 60%.1 Asians generally have a higher percentage of body fat than Caucasians of the same age, sex and BMI. Even below the usual cut-off of BMI = 25 kg/m2 Asian people seem to be at increased risk for type 2 diabetes.2 This may have implications for obesity diagnostic criteria. Indeed, the proposed optimal BMI cut-off values by WHO in Asian populations seems to vary from 22 to 25 kg/m2 based on the ethnic background. A Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians has suggested the following BMI cut-off values: normal BMI = 18.0–22.9 kg/m2; overweight = 23.0–24.9 kg/m2; and obesity > 25 kg/m2.3 Thus it is indeed debatable whether uniform BMI cut-off values to diagnose obesity and/or for cardiovascular risk stratification purposes can be use worldwide. The use of additional anthropometric measurements e.g. waist-circumference or CT based quantification of abdominal/subcutaneous fat volume could help to better delineate obesity and risk parameters and to implement preventive strategies against obesity in each specific ethnic scenario. See Supplementary material online, Appendix. Obesity and overweight are risk factors for the development atherosclerosis. The adipose tissue (AT) was traditionally considered an energy storage organ. However, a large body of evidence highlights the AT as an active endocrine organ that secretes numerous hormones and bioactive molecules.4 These adipokines (or adipocytokines) can act in an endocrine, autocrine and paracrine manner regulating not only AT metabolism, but also other organs, such as liver, muscle, the central nervous system and pancreas. Thus, adipokines represent key regulators of glucose level, lipid metabolism, blood pressure, inflammation, and oxidative stress.5 Several lines of evidence point to adipokine deregulation as the link between obesity and development of cardiovascular disease (CVD).6 Various adipokines, including adiponectin, leptin, omentin, and resistin, have been implicated in modulating the atherogenic environment of the vessel wall by affecting endothelial and arterial smooth muscle cell function, as well as macrophages. Interestingly, certain AT depots show a stronger correlation with obesity-associated co-morbidities than total AT mass, reinforcing the concept of depot-specific metabolic functions.7 The principal depots of white AT (WAT) include the visceral AT (VAT), surrounding the visceral organs, the subcutaneous AT (SAT) located below the skin, and the ectopic AT which consists of non-storage depots. Although overall fat mass is important for the development of obesity-associated co-morbidities, VAT accumulation is an independent risk factor for obesity-related metabolic and CVD.8 This differential impact on cardiovascular risk seems to be related to the adipokines secreted from the different fat depots. Specifically, leptin, mainly secreted by SAT, is positively correlated with body fat whereas adiponectin which is more influenced by VAT is reduced in obesity. One particular ectopic AT depot that has attracted major attention is fat surrounding the vasculature, also known as perivascular AT (PVAT), which appears to play an essential role in the control of vascular function and remodelling.9 In lean individuals PVAT exerts vasodilatory and anti-inflammatory functions. These beneficial actions of PVAT are blunted in obesity where the pro-inflammatory state leads to insulin resistance and increased oxidative stress, thereby contributing to vascular dysfunction and remodelling.9 See Supplementary material online, Appendix. Brown AT (BAT) has a different cellular structure, metabolic profile, and function than WAT. Brown AT dissipates energy by uncoupled UCP-1-mediated respiration resulting in heat production (thermogenesis), increased fatty acid oxidation and decreased lipid storage. Brown AT in humans has been traditionally found in neonates; however, the presence of some BAT depots in human adults has also been reported.10 Initially identified in rodents, beige AT (‘brite’, ‘brown-like’, or ‘inducible brown’ AT) is an inducible form of thermogenic AT with a low UCP-1 content in basal conditions that can be induced to increase energy consumption.11 Although its
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257 · cited 1×
“other hand, high-fat diets can be beneficial for cardiovascular health if salutary vegetable fats are consumed, such as polyunsaturared fatty acids (PUFA) or olive oil-monounsaturated fatty acids (MUFA).(59) See Supplementary material online, Appendix.”
BackgroundSelf-citationRetractedEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 1×
“The paradox was attributed to changes in neurohormonal system, enhanced protection against endotoxin/inflammatory cytokines and increased nutritional and metabolic reserve (‘surplus calorie theory’) in obese patients.(55)”
BackgroundYusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · cited 1×
“Thus, adipokines represent key regulators of glucose level, lipid metabolism, blood pressure, inflammation, and oxidative stress.(5) Several lines of evidence point to adipokine deregulation as the link between obesity and development of cardiovascular disease (CVD).”
BackgroundObesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427 · cited 1×
“men.(43) Obesity is also a risk factor for the progression of paroxysmal to permanent AF.”
BackgroundAdipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Cited by
Vaccarino, V., Badimon, L., Bremner, J. D., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Koller, A., Manfrini, O., Milicic, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy913 · Cited by 404
“The metabolic syndrome is associated with depression(172) and can contribute to the development of vascular endothelial dysfunction.(156) It is also likely that the”
BackgroundSelf-citationPadro, T., Manfrini, O., Bugiardini, R., Canty, J., Cenko, E., De Luca, G., Duncker, D. J., Eringa, E. C., Koller, A., Tousoulis, D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa003 · Cited by 294
Self-citationSalvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092274 · Cited by 98
“There is substantial recognition of the impact of obesity-associated low-grade systemic inflammation on heart microvascular function and of the beneficial effect of body weight reduction on endothelial function, which may manifest as early as 1 week after the initiation of dietary intervention [150,151].”
BackgroundObesity accelerates cardiovascular ageing
Ruperez, C., Madeo, F., de Cabo, R., Kroemer, G., & Abdellatif, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf216 · Cited by 73
Metadata
- Authors
- Badimon, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Estruch, R., Milicic, D., Tousoulis, D., Vasiljevic, Z., Vilahur, G., de Wit, C., & Koller, A.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-10
- Volume
- 38
- Issue
- 25
- Pages
- 1951-1958
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2612075601
- Cited by
- 88
- References
- 23
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehx181
- The paper
- Badimon, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Estruch, R., Milicic, D., Tousoulis, D., Vasiljevic, Z., Vilahur, G., de Wit, C., & Koller, A. (2017). Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.